Tianmeng Lyu
Novartis (United States)(US)
Publications by Year
Research Areas
Statistical Methods and Inference, Statistical Methods in Clinical Trials, Statistical Methods and Bayesian Inference, Gut microbiota and health, Advanced Causal Inference Techniques
Most-Cited Works
- → Test‐retest reproducibility of neurochemical profiles with short‐echo, single‐voxel MR spectroscopy at 3T and 7T(2015)173 cited
- → The lung tissue microbiota of mild and moderate chronic obstructive pulmonary disease(2018)147 cited
- → Neurochemical abnormalities in premanifest and early spinocerebellar ataxias(2018)84 cited
- → Efficacy and safety of omalizumab in Chinese patients with anti‐histamine refractory chronic spontaneous urticaria(2022)36 cited
- → Predicting drug approvals: The Novartis data science and artificial intelligence challenge(2021)33 cited
- → Sensitivity of Volumetric Magnetic Resonance Imaging and Magnetic Resonance Spectroscopy to Progression of Spinocerebellar Ataxia Type 1(2019)32 cited
- → Discriminating sample groups with multi-way data(2016)15 cited
- → Bayesian Inference for a Principal Stratum Estimand on Recurrent Events Truncated by Death(2023)9 cited
- → Design considerations in clinical trials with cure rate survival data: A case study in oncology(2017)5 cited